Lawrence Lamb, an inventor of new cancer therapy set to enter clinical trial at UAB Incysus Therapeutics Inc. has received permission to begin testing a new cancer treatment in patients at the University of Alabama at Birmingham. The new drug-resistant immunotherapy program is based on delivering gamma-delta T cell immunotherapy to…
